Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Josh Kim

CEO
Artos AI
San Francisco, California

Josh is the CEO and co-founder of Artos, a Y Combinator-backed company providing the most scalable AI platform for document creation and management in the life sciences.Josh’s journey began in regulatory, clinical, and commercial strategy roles at leading precision oncology companies, including Ignyta (acquired by Roche in 2017) and Erasca (backed by a16z and ARCH Ventures). At Ignyta, he focused on executing late-stage trials and securing marketing approvals while at Erasca, he worked on early-stage IND strategy and trial design.Inspired by his experiences in biotech and personal interactions with healthcare systems, Josh transitioned to academic research at the University of Chicago where his work centered on developing AI for clinical workflows and drug development, including time-series machine learning techniques to monitor neurodegenerative conditions like Alzheimer’s. His work earned him recognition as the youngest NIH-funded Principal Investigator at the National Institute on Aging, leading collaborations to deploy AI in clinical trials and improve trial site selection and patient recruitment through NLP techniques. Josh graduated summa cum laude from the University of Chicago.

Presentation(s):